The U.S. Food and Drug Administration has approved Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the ...
As the U.S. Congress works to avoid a shutdown of the federal government, the State of Alaska is prepared to continue essential services and minimize disruptions to Alaskans in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback